SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-042168
Filing Date
2020-07-10
Accepted
2020-07-10 16:27:08
Documents
2
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5785
2 POA DOCUMENT poa.txt EX-24.3_928591 3877
  Complete submission text file 0001209191-20-042168.txt   11165
Mailing Address C/O BIOTRANSPLANT INC 196 BOSTON AVE SUITE 2800 MEDFORD MA 02155
Business Address
PERRY MICHAEL S (Reporting) CIK: 0001250379 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39059 | Film No.: 201023410

Mailing Address 28159 AVENUE STANFORD SUITE 220 VALENCIA CA 91355
Business Address 28159 AVENUE STANFORD SUITE 220 VALENCIA CA 91355 661-367-9170
Avita Therapeutics, Inc. (Issuer) CIK: 0001762303 (see all company filings)

IRS No.: 202578762 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences